• The Centers for Disease Control and Prevention on Friday announced that the data it had collected merited an investigation into potential stroke risks for recipients for the Pfizer-BioNTech COVID-19 vaccine.
• “Following the availability and use of the updated (bivalent) COVID-19 vaccines, CDC’s Vaccine Safety Datalink (VSD), a near real-time surveillance system, met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent,” the agency wrote in a press release.

Tagged: COVID-19